Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Services (HCSG) Asset Writedowns and Impairment (2016 - 2019)

Healthcare Services (HCSG) has disclosed Asset Writedowns and Impairment for 11 consecutive years, with $2.5 million as the latest value for Q4 2019.

  • On a quarterly basis, Asset Writedowns and Impairment fell 72.4% to $2.5 million in Q4 2019 year-over-year; TTM through Dec 2019 was $25.5 million, a 50.42% decrease, with the full-year FY2019 number at $25.5 million, down 50.42% from a year prior.
  • Asset Writedowns and Impairment was $2.5 million for Q4 2019 at Healthcare Services, up from $1.5 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $37.1 million in Q1 2018 to a low of $550000.0 in Q3 2015.
  • A 5-year average of $4.6 million and a median of $1.7 million in 2017 define the central range for Asset Writedowns and Impairment.
  • Peak YoY movement for Asset Writedowns and Impairment: tumbled 74.65% in 2015, then soared 3436.86% in 2018.
  • Healthcare Services' Asset Writedowns and Impairment stood at $2.1 million in 2015, then crashed by 32.27% to $1.4 million in 2016, then soared by 57.45% to $2.2 million in 2017, then skyrocketed by 299.42% to $9.0 million in 2018, then tumbled by 72.4% to $2.5 million in 2019.
  • Per Business Quant, the three most recent readings for HCSG's Asset Writedowns and Impairment are $2.5 million (Q4 2019), $1.5 million (Q3 2019), and $3.0 million (Q2 2019).